The Transatlantic Trade and Investment Partnership (TTIP)
EU-US partnership in the support of more open trade
The Transatlantic Trade and Investment Partnership (TTIP) aims to create more open trade between the EU and the U.S. Strengthening the world’s most important trading relationship can serve as a key platform to bring quicker new treatment options to patients. TTIP has the potential to facilitate the development of new medicines and improve health outcomes and support new long-term economic benefits.
What's in it for patients?
Our perspective The innovative pharmaceutical industry supports a comprehensive and ambitious agreement that promotes regulatory compatibility, strengthens intellectual property protection, and enhances patient access to innovative medicines. Moreover, increased regulatory compatibility can, for example, be expected to have a particularly positive impact on smaller companies and collaborations that are central to the broader life sciences ecosystem. EPFIA strongly believes that a strong TTIP agreement can help accelerate global development of medicines and enhance patient access to much-needed innovative medicines.
What's in it for patients?
Our perspective The innovative pharmaceutical industry supports a comprehensive and ambitious agreement that promotes regulatory compatibility, strengthens intellectual property protection, and enhances patient access to innovative medicines. Moreover, increased regulatory compatibility can, for example, be expected to have a particularly positive impact on smaller companies and collaborations that are central to the broader life sciences ecosystem. EPFIA strongly believes that a strong TTIP agreement can help accelerate global development of medicines and enhance patient access to much-needed innovative medicines.
Supporting downloads
- TTIP and healthcare: Separating fact from fiction get_app
- The EU – US TTIP - Impact on EU economy, society and patients get_app
- TTIP- the benefits for patients, healthcare, science and business get_app
- The EU-U.S. TTIP - Towards better health outcomes for patients and economic growth-Desk get_app
- How a strong pharmaceutical chapter in TTIP will benefit the EU get_app
Related pages
